Renoprotective effects of HMG/CoA reductase inhibitor on patients with hyperlipidemia associated with renal insufficiency-Effect of atorvastatin by switching from other statins
Not Applicable
- Conditions
- Diabetes Mellitus
- Registration Number
- JPRN-UMIN000007703
- Lead Sponsor
- Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
The exclusion criteria were an age >70 years, current history of myocardial infarction and/or cerebral stroke, uncontrollable hypertension and hyperglycemia, renal failure, abnormal liver or muscle enzymes (ALT>100, ALT>100), patients who applied for other clinical trial within 3 months, expectant mother, lactating woman, patients who had taken ACE-I and/or ARB within 3 months, inappropriate patients judged by the physician in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method